Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/6/2026

Precautions for Preparing and Using 100 % Trichloroacetic Acid (TCA) in Dermatology Clinics

Application Technique and Control

  • Apply TCA only to the target wart or lesion using controlled applicators (e.g., a 27‑gauge tuberculin syringe) to prevent spread to surrounding normal tissue. [CDC 1]
  • Ensure the treatment area is completely dry before applying TCA to avoid uncontrolled spread of the acid. [CDC 3]
  • Limit each treatment session to a surface area that can be safely managed in one application; large areas increase risk of systemic absorption. [CDC 1]

Immediate Neutralization Protocol

  • Immediately powder the treated area with talc or sodium bicarbonate after TCA application to neutralize any unreacted acid. [CDC 1]
  • If excess acid is applied, neutralize the site with talc, sodium bicarbonate, or liquid soap preparations to prevent tissue damage. [CDC 4]
  • Keep neutralizing agents (talc, sodium bicarbonate, soap) readily accessible at the treatment site for rapid use. [CDC 2]

Eye Protection – Critical Safety Measure

  • Both patient and provider must wear protective eyewear during any TCA application to prevent ocular exposure. [International Journal of Oral Science 6]

Personal Protective Equipment (PPE)

  • Wear protective gloves when handling concentrated TCA to avoid skin contact. [CDC 7]
  • Use protective eyewear with solid side shields or a face shield to protect mucous membranes from splashing. [CDC 7]
  • Wear protective clothing that covers forearms and any exposed personal clothing. [CDC 7]
  • Remove all barrier protection (gloves, gowns, eyewear) before leaving the treatment area to prevent cross‑contamination. [CDC 7]

Storage and Handling

  • Store TCA in clearly labeled containers that document concentration and preparation method, and keep them in a secure location away from general clinic supplies. [CDC 5]
  • Maintain stable shelf‑life conditions and verify the solution’s concentration periodically, as stability may vary over time. [CDC 2]

Treatment Endpoint and Monitoring

  • The visual endpoint of TCA application is the appearance of a white frosting or discoloration of the treated skin. [CDC 1]
  • Allow the acid to dry completely before the patient moves or the treated area contacts clothing to prevent accidental spread. [CDC 5]
  • Monitor for excessive application, which can cause the acid to spread to adjacent normal tissue. [CDC 5]

Safety Limits and Patient Selection

  • Do not apply TCA to surface areas larger than approximately 10 cm² in a single session because of the risk of systemic absorption. [CDC 1]
  • Avoid over‑application; the low viscosity of TCA solutions permits rapid spread comparable to water. [CDC 5]
  • Do not use TCA on patients who cannot remain still during application and drying, as movement increases the risk of unintended spread. [CDC 2]